Jeffrey S. Ginsberg

25.7k total citations · 4 hit papers
208 papers, 16.5k citations indexed

About

Jeffrey S. Ginsberg is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Jeffrey S. Ginsberg has authored 208 papers receiving a total of 16.5k indexed citations (citations by other indexed papers that have themselves been cited), including 162 papers in Internal Medicine, 131 papers in Cardiology and Cardiovascular Medicine and 83 papers in Hematology. Recurrent topics in Jeffrey S. Ginsberg's work include Venous Thromboembolism Diagnosis and Management (162 papers), Atrial Fibrillation Management and Outcomes (87 papers) and Blood Coagulation and Thrombosis Mechanisms (79 papers). Jeffrey S. Ginsberg is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (162 papers), Atrial Fibrillation Management and Outcomes (87 papers) and Blood Coagulation and Thrombosis Mechanisms (79 papers). Jeffrey S. Ginsberg collaborates with scholars based in Canada, United States and Netherlands. Jeffrey S. Ginsberg's co-authors include Jack Hirsh, Shannon M. Bates, Susan R. Kahn, Jeffrey I. Weitz, Wee‐Shian Chan, Mark Crowther, Michael Gent, Clive Kearon, William Geerts and Patrick Brill-Edwards and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Jeffrey S. Ginsberg

204 papers receiving 15.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis

1996 872 citations Mark Levine, Michael Gent et al. New England Journal of Medicine profile →
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism

2003 544 citations Clive Kearon, Jeffrey S. Ginsberg et al. New England Journal of Medicine profile →
Oral Thrombin Inhibitor Dabigatran Etexilate vs North American Enoxaparin Regimen for Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

2008 490 citations Jeffrey S. Ginsberg, Bruce L. Davidson et al. profile →
The Postthrombotic Syndrome: Evidence-Based Prevention, Diagnosis, and Treatment Strategies

2014 384 citations Susan R. Kahn, Jeffrey S. Ginsberg et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey S. Ginsberg Canada	67	12.2k	9.4k	5.4k	5.1k	2.1k	208	16.5k
Giancarlo Agnelli Italy	45	11.7k 1.0×	8.7k 0.9×	3.9k 0.7×	2.5k 0.5×	2.6k 1.2×	180	13.9k
Walter Ageno Italy	67	13.7k 1.1×	11.4k 1.2×	4.0k 0.7×	3.6k 0.7×	1.9k 0.9×	557	20.5k
Gary E. Raskob United States	58	13.3k 1.1×	11.1k 1.2×	4.8k 0.9×	3.2k 0.6×	2.3k 1.1×	170	19.6k
Anthonie W.A. Lensing Netherlands	41	9.2k 0.8×	6.8k 0.7×	3.1k 0.6×	2.7k 0.5×	2.0k 0.9×	91	11.0k
Graham F. Pineo Canada	34	8.9k 0.7×	7.2k 0.8×	4.2k 0.8×	1.6k 0.3×	1.5k 0.7×	116	12.1k
Anna Falanga Italy	65	9.2k 0.8×	5.3k 0.6×	2.3k 0.4×	5.1k 1.0×	2.8k 1.3×	299	16.8k
Henri Bounameaux Switzerland	58	17.4k 1.4×	11.4k 1.2×	5.6k 1.0×	3.2k 0.6×	3.3k 1.6×	222	20.9k
Russell D. Hull Canada	61	13.3k 1.1×	9.0k 1.0×	5.5k 1.0×	2.4k 0.5×	2.3k 1.1×	242	16.4k
Ingrid Pabinger Austria	73	9.3k 0.8×	6.1k 0.6×	2.5k 0.5×	10.5k 2.1×	1.7k 0.8×	541	20.3k
Marc Carrier Canada	51	8.1k 0.7×	5.6k 0.6×	2.3k 0.4×	1.8k 0.4×	2.5k 1.2×	388	11.0k

Countries citing papers authored by Jeffrey S. Ginsberg

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Ginsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Ginsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Ginsberg more than expected).

Fields of papers citing papers by Jeffrey S. Ginsberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Ginsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Ginsberg. The network helps show where Jeffrey S. Ginsberg may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Ginsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Ginsberg. A scholar is included among the top collaborators of Jeffrey S. Ginsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Ginsberg. Jeffrey S. Ginsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nicholson, Matthew C., Noel Chan, Vinai Bhagirath, & Jeffrey S. Ginsberg. (2020). Prevention of Venous Thromboembolism in 2020 and Beyond. Journal of Clinical Medicine. 9(8). 2467–2467. 103 indexed citations

Hirsh, Jack, Vinai Bhagirath, Jeffrey S. Ginsberg, et al.. (2018). Impact of cost on use of non-vitamin K antagonists in atrial fibrillation patients in Ontario, Canada. Journal of Thrombosis and Thrombolysis. 46(3). 310–315. 3 indexed citations

Chan, Noel, Michiel Coppens, J. Hirsh, et al.. (2014). Real‐world variability in dabigatran levels in patients with atrial fibrillation. Journal of Thrombosis and Haemostasis. 13(3). 353–359. 61 indexed citations

Linkins, Lori‐Ann, Shannon M. Bates, Eddy Lang, et al.. (2013). Selective D-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis. Annals of Internal Medicine. 3 indexed citations

Morris, Timothy A., Michael Gerometta, Roger D. Yusen, et al.. (2011). Detection of Pulmonary Emboli With 99mTc-Labeled Anti–D-dimer (DI-80B3)Fab′ Fragments (ThromboView). American Journal of Respiratory and Critical Care Medicine. 184(6). 708–714. 17 indexed citations

Andreou, Εleni, Tulay Koru‐Sengul, Lori‐Ann Linkins, et al.. (2008). Differences in clinical presentation of deep vein thrombosis in men and women. Journal of Thrombosis and Haemostasis. 6(10). 1713–1719. 35 indexed citations

Kearon, Clive, Jim A. Julian, Michael J. Kovacs, et al.. (2008). Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial. Blood. 112(12). 4432–4436. 81 indexed citations

Kearon, Clive, Jeffrey S. Ginsberg, James D. Douketis, et al.. (2006). An Evaluation of D-Dimer in the Diagnosis of Pulmonary Embolism. Annals of Internal Medicine. 7 indexed citations

Johnston, Joseph A., Patrick Brill-Edwards, Jeffrey S. Ginsberg, Stephen G. Pauker, & Mark H. Eckman. (2005). Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. The American Journal of Medicine. 118(5). 503–514. 18 indexed citations

10.

Kahn, Susan R., Clive Kearon, J.A. Julian, et al.. (2005). Predictors of the post‐thrombotic syndrome during long‐term treatment of proximal deep vein thrombosis. Journal of Thrombosis and Haemostasis. 3(4). 718–723. 147 indexed citations

11.

Bates, Shannon M., et al.. (2005). "ProC Global": A functional screening test that predicts recurrent venous thromboembolism. Thrombosis and Haemostasis. 93(3). 600–604. 7 indexed citations

12.

McRae, Simon & Jeffrey S. Ginsberg. (2005). The Diagnostic Evaluation of Pulmonary Embolism. The American Heart Hospital Journal. 3(1). 14–20. 3 indexed citations

13.

McRae, Simon & Jeffrey S. Ginsberg. (2005). New anticoagulants for venous thromboembolic disease. Current Opinion in Cardiology. 20(6). 502–508. 6 indexed citations

14.

Bates, Shannon M., Ian A. Greer, Jack Hirsh, & Jeffrey S. Ginsberg. (2004). Use of Antithrombotic Agents During Pregnancy. CHEST Journal. 126(3). 627S–644S. 341 indexed citations

15.

Rosenbloom, David & Jeffrey S. Ginsberg. (2002). Arguments against Monitoring Levels of Anti-Factor Xa in Conjunction with Low-Molecular-Weight Heparin Therapy. The Canadian Journal of Hospital Pharmacy. 55(1). 5 indexed citations

16.

Francis, Charles W., Bruce L. Davidson, Scott D. Berkowitz, et al.. (2002). Ximelagatran versus Warfarin for the Prevention of Venous Thromboembolism after Total Knee Arthroplasty. Annals of Internal Medicine. 47 indexed citations

17.

Kraaijenhagen, Roderik A., Anthonie W.A. Lensing, Jeroen G. Lijmer, et al.. (1997). Diagnostic strategies for the management of patients with clinically suspected deep-vein thrombosis. Current Opinion in Pulmonary Medicine. 3(4). 268–274. 25 indexed citations

18.

Levine, Mark, Michael Gent, Jack Hirsh, et al.. (1996). A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 334(11). 677–681. 872 indexed citations breakdown →

19.

Ginsberg, Jeffrey S. & William M. Barron. (1994). Pregnancy and prosthetic heart valves. The Lancet. 344(8931). 1170–1172. 33 indexed citations

20.

Weitz, Jeffrey I., Moira Cruickshank, Bob Thong, et al.. (1988). Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.. Journal of Clinical Investigation. 82(5). 1700–1707. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact